Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 162
Infectious Diseases Drugs 123
Genomics 101
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 51
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 36
HIV/AIDS Drugs 36
Lymphoma Drugs 29
Allergy and Immunology 28
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Respiratory Drugs 26
Oncology 22
Pulmonary Medicine 21
Central Nervous System Drugs 20
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Women's Health 6
Lung Cancer Drugs 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

1,019 Results (Page 18 of 51)
- Relevance
  Sort by

Top Ten Suppliers of Synthetic Biology Technology

 Report
January 2024
161 Pages
Global

From

€4162EUR$4,650USD£3,636GBP

Bio/Pharmaceutical Outsourcing Report, May 2025

 Report
May 2025
24 Pages
Global

From

€2641EUR$2,950USD£2,307GBP

Breast Cancer Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Drug Pipelines
July 2024
100 Pages
Global

From

€3357EUR$3,750USD£2,932GBP

Hospital Injectable Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
October 2024
99 Pages
Global

From

€3500EUR$4,189USD£3,164GBP

Immuno-oncology Market

 Report
January 2024
200 Pages
Global

From

€3715EUR$4,150USD£3,245GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Ulcerative Colitis Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

 Report
March 2025
99 Pages
Global

From

€3500EUR$4,189USD£3,164GBP

Gastrointestinal Collaboration and Licensing Deals 2016-2025

 Report
October 2025
250 Pages
Global

From

€3576EUR$3,995USD£3,124GBP

Hematologic Malignancies Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
111 Pages
Global

From

€4252EUR$4,750USD£3,714GBP

Pancreatic Cancer - Pipeline Review, H2 2020

 Drug Pipelines
September 2020
4317 Pages
Global

From

€2238EUR$2,500USD£1,955GBP

Alcoholic Hepatitis Treatment Market Report and Forecast 2024-2032

 Report
November 2023
170 Pages
Global

From

€3222EUR$3,599USD£2,814GBP

Opioid Antagonist Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

 Report
January 2024
100 Pages
Global

From

€3500EUR$4,189USD£3,164GBP

Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1119EUR$1,250USD£977GBP

IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1119EUR$1,250USD£977GBP

Lyophilization Equipment And Services - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

 Report
May 2025
130 Pages
Global

From

€4252EUR$4,750USD£3,714GBP

Acute Lung Injury Treatment Market Report and Forecast 2023-2031

 Report
June 2023
180 Pages
Global

From

€4430EUR$4,949USD£3,870GBP

Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
700 Pages
Global

From

€2238EUR$2,500USD£1,955GBP

Engineered T Cells Market - Global Forecast 2026-2032

 Report
January 2026
184 Pages
Global

From

€3173EUR$3,545USD£2,772GBP

€3526EUR$3,939USD£3,080GBP

Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
322 Pages
Global

From

€2238EUR$2,500USD£1,955GBP

Cryptococcal Meningitis - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1119EUR$1,250USD£977GBP

Cystic Fibrosis Treatment Market Report and Forecast 2023-2031

 Report
April 2023
160 Pages
Global

From

€4430EUR$4,949USD£3,870GBP

1,019 Results (Page 18 of 51)
- 1
- 16
- 17
- 18
- 19
- 20

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.